This information is intended for Healthcare Professionals
You will now be re-directed to www.pfizermedicalinformation.com
Sasanlimab is an investigational compound. Its safety and efficacy have not been established.
Non-muscle Invasive Bladder Cancer
Phase 3
NCT04165317
Back
